PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $58,751 | -46.2% | 18,651 | -50.3% | 0.00% | -50.0% |
Q2 2020 | $109,108 | +3.4% | 37,494 | +0.2% | 0.00% | 0.0% |
Q1 2020 | $105,570 | -17.1% | 37,436 | -4.6% | 0.00% | 0.0% |
Q4 2019 | $127,327 | +169.9% | 39,238 | +79.6% | 0.00% | +100.0% |
Q3 2019 | $47,179 | -67.7% | 21,842 | -53.0% | 0.00% | -50.0% |
Q2 2019 | $145,891 | -15.6% | 46,462 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $172,839 | +26.6% | 46,462 | -1.3% | 0.00% | 0.0% |
Q4 2018 | $136,515 | +10.3% | 47,074 | 0.0% | 0.00% | +50.0% |
Q3 2018 | $123,805 | -99.9% | 47,074 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $110,153,000 | -20.4% | 47,074 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $138,398,000 | +121301.8% | 47,074 | +12.9% | 0.00% | 0.0% |
Q4 2017 | $114,000 | -70.7% | 41,688 | -63.7% | 0.00% | 0.0% |
Q3 2017 | $389,000 | +35.5% | 114,844 | -1.3% | 0.00% | 0.0% |
Q2 2017 | $287,000 | +14.8% | 116,377 | +5.7% | 0.00% | 0.0% |
Q1 2017 | $250,000 | 0.0% | 110,091 | -6.8% | 0.00% | 0.0% |
Q4 2016 | $250,000 | -36.1% | 118,076 | +1.1% | 0.00% | -33.3% |
Q3 2016 | $391,000 | +7.7% | 116,837 | +1.2% | 0.00% | 0.0% |
Q2 2016 | $363,000 | -5.5% | 115,462 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $384,000 | -6.1% | 115,462 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $409,000 | -29.6% | 115,462 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $581,000 | -9.2% | 115,462 | +16.1% | 0.00% | 0.0% |
Q2 2015 | $640,000 | -28.4% | 99,457 | -21.7% | 0.00% | -42.9% |
Q1 2015 | $894,000 | -9.1% | 127,017 | -0.4% | 0.01% | 0.0% |
Q4 2014 | $983,000 | +3.3% | 127,469 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $952,000 | -25.5% | 127,469 | -3.4% | 0.01% | -22.2% |
Q2 2014 | $1,277,000 | +21.0% | 131,917 | +3.9% | 0.01% | +28.6% |
Q1 2014 | $1,055,000 | +4.9% | 126,998 | +6.6% | 0.01% | 0.0% |
Q4 2013 | $1,006,000 | +5.9% | 119,167 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $950,000 | +3.3% | 119,167 | 0.0% | 0.01% | 0.0% |
Q2 2013 | $920,000 | – | 119,167 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |